Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistPharmacy2Home/LandiCom Holding LTD was cited for selling unapproved and misbranded drug products through their website (pharmacy2home.com) that claimed to mitigate, prevent, treat, diagnose, or cure COVID-19 and other diseases including influenza, malaria, and rheumatoid arthritis, violating sections 505(a) and 502 of the Federal Food, Drug, and Cosmetic Act. The company's products lacked FDA approval or authorization and were introduced into interstate commerce without proper regulatory compliance. The FDA took particular enforcement priority due to the declared public health emergency and presidential declaration of national emergency related to COVID-19, citing inherent risks to consumers purchasing these unauthorized products.